Home > News > UF Radiologists Among The First 10 In The U.S. To Kill Soft-Cell Cancer Tumors With The IRE NanoKnife
April 4th, 2010
UF Radiologists Among The First 10 In The U.S. To Kill Soft-Cell Cancer Tumors With The IRE NanoKnife
Abstract:
Radiologists at Shands at the University of Florida have used nanotechnology to precisely deliver electrical currents to destroy tumor cells in a patient with colon cancer.
On Feb. 25, James Caridi, M.D., and Jeffrey Vogel, M.D., interventional radiologists with the UF College of Medicine and the UF Shands Cancer Center, led a team using the IRE NanoKnife system to remove a malignant liver tumor in a 52-year-old patient with metastatic colon cancer.
Only 10 teams in the United States and 20 worldwide have used the technology, produced by AngioDynamics, Inc.
It works by using computerized tomography or ultrasound imaging to guide two or more fine-needle electrodes into the tumor. The electrodes deliver high-voltage, pulsating electrical currents that open microscopic pores in the cancer cells, rapidly killing the tumor. After such treatment, the body naturally removes the dead cancer cells.
"Interventional radiology is a rapidly emerging specialty in the oncology arena," Caridi said. "We use precise imaging to diagnose and guide treatment of tumors using minimally invasive techniques."
Source:
wctv.tv
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||